Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Butter and total cholesterol]

H Immich

    Versicherungsmedizin
    |December 1, 1993
    PubMed
    Summary
    This summary is machine-generated.

    Restricting butter intake does not affect blood cholesterol levels. High cholesterol is not definitively linked to coronary sclerosis, and serum cholesterol is no longer considered a risk factor.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Papassotiropoulos et al., "The risk of acute suicidality in psychiatric in-patients increases with low plasma cholesterol" (Pharmacopsychiatry 32 (1999) 1-4)

    Pharmacopsychiatry·1999
    Same author

    [Odds ration and relative risk: confounded effects?].

    Versicherungsmedizin·1999
    Same author

    [Critical commentary about the CARE study].

    Versicherungsmedizin·1998
    Same author

    [Cholesterol and coronary sclerosis].

    Versicherungsmedizin·1997
    Same author

    [Causes of coronary heart disease].

    Lebensversicherungs Medizin·1987
    Same author

    [Does phenacetin cause cancer?].

    Deutsche medizinische Wochenschrift (1946)·1987
    Same journal

    [What do company health insurance plans provide?]

    Versicherungsmedizin·2017
    Same journal

    [Assessment of prescriptive therapies and remedies - Experience and results].

    Versicherungsmedizin·2017
    Same journal

    [The importance of biosimilars medicines for private and statutory health insurance].

    Versicherungsmedizin·2017
    Same journal

    [Can we transfer the mechanisms of the generics market to biosimilars?]

    Versicherungsmedizin·2017
    Same journal

    [Not Available].

    Versicherungsmedizin·2016
    Same journal

    [Not Available].

    Versicherungsmedizin·2016
    See all related articles

    Area of Science:

    • Cardiovascular Science
    • Nutritional Epidemiology
    • Biochemistry

    Background:

    • Elevated serum cholesterol is traditionally considered a primary risk factor for coronary artery disease.
    • Butter consumption has been debated regarding its impact on cardiovascular health and cholesterol levels.
    • Previous intervention studies have yielded inconclusive results on cholesterol-lowering effects.

    Purpose of the Study:

    • To critically evaluate the role of butter consumption on physiological cholesterol levels.
    • To investigate the association between high cholesterol and the incidence of coronary sclerosis.
    • To reassess the validity of serum cholesterol as a cardiovascular risk factor.

    Main Methods:

    • Review of existing literature on dietary fat intake and cholesterol metabolism.

    Related Experiment Videos

  • Analysis of epidemiological data correlating cholesterol levels with coronary sclerosis incidence.
  • Evaluation of outcomes from historical cholesterol-lowering intervention trials.

    • Main Results:

    • Limited butter consumption showed no significant impact on physiological cholesterol levels.
    • A demonstrable association between high cholesterol and coronary sclerosis incidence was not established.
    • Intervention trials targeting cholesterol reduction have not demonstrated a significant effect on cardiovascular outcomes.

    Conclusions:

    • Serum cholesterol levels may not be a reliable indicator of coronary sclerosis risk.
    • Dietary interventions focusing solely on cholesterol reduction might be ineffective for preventing cardiovascular disease.
    • Re-evaluation of current cardiovascular risk assessment models is warranted.